drugset / Trial / NCT07515391
Dapagliflozin Effect on Glucose Variability in Patients Post Bariatric Surgery
Phase 2
Enrolling by invitation
30 enrolled
Dasman Diabetes Institute
Kuwait Foundation for the Advancement of Sciences · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study evaluates the effect of SGLT-2 inhibitors (dapagliflozin) on the blood glucose excursions by a continuous glucose monitoring system, the incidence of hypoglycemia and hyperglycemia and change in glycated hemoglobin (HbA1c) level in people had bariatric surgery with and without type 2 diabetes.
Timeline
- Start
- 2019-10-22
- Primary completion
- 2021-05-01
- Completion
- 2026-10-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dapagliflozin | Small molecule | 10 mg | — |